検索結果

sident: Mr. Naoyuki Mochida; hereinafter: Mochida) and developed by Senju as an eye drop treatment for Dry Eye Disease (DED), has been launched in Japan today. Avarept® represents a novel therapy for ...

Co., Ltd. Mochida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Recep...

Overseas Activities | SENJU Pharmaceutical

Eye health and pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we ent...

Overseas Activities | SENJU Pharmaceutical

Eye health and pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we ent...

Research and Development System | Research & Development | SENJU Pharmaceutica

All things in nature have a reason for being.Today’s common sense may not be common sense tomorrow. At Senju Pharmaceutical, we are dedicated not only to our original R&D initiatives but also to R...